跳至主要内容
临床试验/NCT05805735
NCT05805735已完成不适用

Anti-Wrinkle Efficacy Study

Amazentis SA1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2023年3月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Amazentis SA
入组人数
36
试验地点
1
主要终点
Anti-wrinkle efficacy will be assessed in the periorbital regions wrinkles using DermaTOP. Parameters measured: Rz and Ra, representing mainly the rough structure (Rz) or the finer skin structure (Ra).

研究概览

简要总结

The purpose of this study is to assess the anti-aging and reduction of dark circles efficacy of a cosmetic product after 8 weeks of application.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

盲法说明

Blinding of sponsor label (de-branded product)

入排标准

年龄范围
40 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Written informed consent to participate in the study
  • Willingness to actively participate in the study and to come to the scheduled visits
  • Female and male (approx. 10% male)
  • Between 40 and 65 years of age
  • Visible wrinkles in the periorbital regions in accordance with the study site's score of at least grade 3
  • Dark circles according to self-assessment (not guaranteed on darker skin types)
  • Healthy skin in the test areas
  • Uniform skin color and no erythema or dark pigmentation (except dark cycles are still visible) in the test area

排除标准

  • Female subjects: Pregnancy or lactation
  • Drug addicts, alcoholics
  • AIDS, HIV-positive or infectious hepatitis
  • Conditions which exclude a participation or might influence the test reaction/evaluation
  • Participation or being in the waiting period after participation in cosmetic and/or pharmaceutical studies pertaining to the test area
  • Cancer not being diagnosed as cured and requiring chemotherapy, irradiation and/or hormonal treatment within the last 2 years
  • One of the following illnesses with reduced physical capability/fitness: asthma (symptom-free allergic asthma is not an exclusion criterion), hypertension (if not adjusted with medication), cardiovascular diseases
  • Insulin-dependent diabetes mellitus
  • Any topical medication at the test area within the last 7 days prior to the start of the study and/or throughout the entire course of the study
  • Documented allergies to face care or cleansing products
  • Active skin disease at the test area
  • Wounds, moles, tattoos, scars, irritated skin, excessive hair growth, etc. at the test area that could influence the investigation
  • Past cosmetic surgery procedure in the test area (e.g. laser, facelift)
  • Cosmetic surgery procedure in the test area, e.g. IPL (Intensed Pulsed Light), botox, chemical peel, dermabrasion within the last 2 years prior to the start of the study
  • Obesity with a BMI > 40
  • Systemic therapy with immuno-suppressive drugs (e.g. corticosteroids) and/or antihistamines (e.g. antiallergics) and/or within the last 7 days prior to the start of the study
  • Medical treatment for wrinkle reduction (e.g. peeling with vitamin A or fruit acids) on the face within the last 2 weeks prior to the start of the study

结局指标

主要结局

Anti-wrinkle efficacy will be assessed in the periorbital regions wrinkles using DermaTOP. Parameters measured: Rz and Ra, representing mainly the rough structure (Rz) or the finer skin structure (Ra).

时间窗: 8-weeks

次要结局

  • Subjective Evaluation of product traits assessed via questionnaire after 2, 4 and 8 weeks(8-weeks)
  • Assessment of eye area puffiness by photo ranking by 3 trained graders(8-weeks)
  • Change from baseline in skin elasticity by Cutometer after 2, 4 and 8 weeks(8-weeks)
  • Change from baseline in skin hydration (assessed on skin capacitance by Corneometer [a.u.]) after 2, 4 and 8 weeks(8-weeks)
  • Dark circles color in difference by ColorFace image analysis Clinical assessment of dark circle reduction around the eye area by trained grader(8-weeks)
  • Change from baseline in skin firmness by Cutometer [mm] after 2, 4 and 8 weeks(8-weeks)
  • Clinical assessment of dark circle reduction by trained grader(8-weeks)
  • Change from baseline in skin barrier function (assessed on transepidermal waterloss by Tewameter [g/(m²h)]) after 2, 4, 8-weeks(8-weeks)
  • Photo documentation of skin by ColorFace(8-weeks)

研究者

发起方
Amazentis SA
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验